AI Stock Finder
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-06

EPRX vs KMDA: stock comparison and AI forecast

Eupraxia Pharmaceuticals Inc. (EPRX) and Kamada Ltd (KMDA) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Pharmaceutical Preparations

EPRX Eupraxia Pharmaceuticals Inc.

Market Cap
$435M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Nasdaq · Pharmaceutical Preparations

KMDA Kamada Ltd

Market Cap
$418M
P/E Ratio
11.3x
Size
small-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

EPRX · KMDA

Key facts

  • EPRX and KMDA have similar market capitalizations ($435M and $418M).
  • Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricEPRXKMDA
Market Cap$435M$418M
P/E Ratio–11.33x
P/B Ratio5.30x–
EPS–$0.64
Book Value/Share$1.25–
Revenue/Share–$5.48

Profitability & Margins

MetricEPRXKMDA
ROE–11.6%
ROA–8.2%
Gross Margin–43.0%
Operating Margin–15.5%
Net Margin–9.8%
EBT Margin–13.3%
Tax Rate–12.7%

Financial Health

MetricEPRXKMDA
Current Ratio15.12x–
D/E Ratio0.07x–
Financial Leverage1.05x1.41x
Working Capital$79M–

Cash Flow

MetricEPRXKMDA
Operating Cash Flow–$43M
OCF Growth YoY–-48.2%

Operational Efficiency

MetricEPRXKMDA
Asset Turnover–0.84x
Inventory Turnover–2.1x
Fixed Assets Turnover–7.6x
Days Inventory–172 days
Payables Period–47 days

Income Statement

MetricEPRXKMDA
Total Revenue–$316M
Operating Income–$49M
Net Income–$31M
R&D Expense–$23M
Cost of Goods Sold–$180M

Dividend & Shareholder Information

MetricEPRXKMDA
Shares Outstanding66M58M
EPS Growth–45.5%
FAQ

EPRX vs KMDA: stock comparison and AI forecast

Which is bigger, EPRX or KMDA?

EPRX and KMDA have similar market capitalizations ($435M and $418M).

Which one does Intratio's AI model rank higher, EPRX or KMDA?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.